FDA Chaos and Foreign Price Controls Are Collapsing American Innovation
FDA reversals and price controls are handing biotech dominance to China. We expose the national security crisis in drug development.
The FDA is facing a crisis of confidence that threatens the stability of the entire US biopharmaceutical industry. In this episode, John Stanford is joined by Jef Akst, Managing Editor at BioSpace, to expose how recent "regulatory reversals" and inconsistent decision-making are rendering major vaccine and therapeutic programs "uninvestable". We analyze the shocking "Moderna gate" incident, where the FDA issued a "refuse to file" letter for an mRNA flu vaccine…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.